A Biotech Giant Not Named Biogen Also Had a Good Week

Bookmark
(Bloomberg Opinion) -- Vertex Pharmaceuticals Inc., a nearly $50 billion biotech company that develops treatments for just one rare disease, is having a truly excellent week.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.